Adverse Effects Generally Mild After BNT162b2 mRNA Booster in Over 60s

MONDAY, April 18, 2022 (HealthDay News) -- Adverse effects (AEs) after the booster BNT162b2 mRNA vaccine dose are generally mild and similar to those reported after the second dose, according to a research letter published online April 18 in JAMA Network Open.
Oren Auster, from Clalit Research Institute in Tel Aviv, Israel, and colleagues examined the occurrence of AEs in adults aged 60 years or older who received a BNT162b2 booster dose at least five months after receipt of a second dose. Study participants received the booster dose in the first five days of the campaign (July 30 to Aug. 3, 2021).
Overall, 27,046 individuals responded to the survey (median age, 71 years). The researchers found that 30.0 percent of participants reported at least one AE; 24.8 and 16.6 percent reported local and systemic reactions, respectively. Pain at the injection site, fatigue, and malaise were the most common AEs (23.5, 9.7, and 7.2 percent, respectively). Overall, 67.8, 18.7, and 11.1 percent of the respondents reported that their general feeling after the booster dose was similar to the feeling after the second dose, reported a milder response, or reported a worse response, respectively. Medical attention was sought by 1.2 percent owing to an AE. Women were more likely to report an AE than men (39.0 versus 22.6 percent).
"We found that AEs after the BNT162b2 mRNA vaccine booster dose were generally mild and usually did not require medical care," the authors write. "The proportion of self-reported AEs that occurred in our study was similar or lower than that after the administration of the second vaccine dose in several previous studies."
Several authors reported receiving institutional grants from Pfizer to the Clalit Research Institute.
Related Posts
AHA News: Hola, papás: Ustedes tienen un papel de gran importancia en la salud de sus hijos
JUEVES, 15 de junio de 2023 (American Heart Association News) -- Los papás...
HIV & Hepatitis Can Be Deadly Combo for the Heart
WEDNESDAY, Sept. 21, 2022 (HealthDay News) -- As people with HIV age, their odds...
STDs May Be More Common Than Thought Among U.S. High School Kids
MONDAY, April 11, 2022 (HealthDay News) -- Too few sexually active teens are...
Deadly Liver Disease Tied to Obesity Is on the Rise
FRIDAY, Oct. 22, 2021 (HealthDay News) -- Liver disease is usually associated...